Article

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort

2023-09-01

Abstract excerpt

<h4>Background</h4> Genetic polymorphisms have been associated with risk of anti-tuberculosis treatment toxicity. We characterized associations with adverse events and treatment failure/recurrence among adults treated for tuberculosis in Brazil. <h4>Methods</h4> Participants were followed in Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil. We included persons with culture-confirmed drug...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c5e6db4c-91bf-5496-aba5-fc985b72f025
DOI: 10.1101/2023.08.30.23294860

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohortDOI 10.1101/2023.08.30.23294860Read

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.Semantic proximity Read

Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis.Semantic proximity Read

NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic CohortSemantic proximity Read

Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis.Semantic proximity Read

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review.Semantic proximity Read

NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization.Semantic proximity Read

Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs.Semantic proximity Read

Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidenceSemantic proximity Read

tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.Semantic proximity Read

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis.Semantic proximity Read

Genetic polymorphisms and adverse reactions to antituberculosis therapySemantic proximity Read

NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.Semantic proximity Read